Across 6 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Browse the detailed record of transactions filed by Spangler Patrick D, Director. Director active across 1 company, notably OptimizeRx Corp. Aggregated, 9 filings have been logged. Split: 0 buy · 2 sells. Total volume traded: €919k. Activity tracked since 30 June 2021. The latest transaction was disclosed on 5 June 2024 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
9 of 9 declarations
Patrick D. Spangler is a Board Member at OptimizeRx Corp. He plays a key role in the strategic direction of the company, contributing to important decision-making and overseeing operations. His significant experience in the sector is an asset for corporate governance.